Clinical Trial Update: Circulating Tumor Cells for Hepatocellular Carcinoma

View source ↗

Summary

An update on a clinical trial investigating circulating tumor cells as a biomarker in hepatocellular carcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Carcinoma, Hepatocellular, Neoplasm Circulating Cells | Status: UNKNOWN